Hemodynamics, fluids & transfusion

Detection of hypovolemia by non-invasive hemodynamic monitoring during major surgery using Ringer´s solution, 5% albumin, or 20% albumin as infusion fluid: a post-hoc analysis of a randomized clinical trial

Crit CarePublished Secondary analysis of a randomised controlled trial

Authors' conclusion

The trends in PPV, PVI, and CO reflected the changes in intravascular volume, but how well they indicated hypovolemia > 500 mL may differ depending on the choice of infusion fluid.

Study context

Population
Patients with hemorrhage during major surgery
Participants
42 patients
Comparison
5% albumin vs 20% albumin vs Ringer
Primary endpoint
Ability of PPV, PVI, CO and Guyton's approach to detect hypovolemia
Methodological detailspost-hoc analysis, single-centre
  • Post-hoc analysis
  • Single-centre

Primary result

As reported in the abstract

Detection of hypovolemia > 500 mL (ROC curves)
  • Hypovolemia > 500 mL accurately detected by PPV only with 5% albumin
  • Plethysmographic variation index (PVI) reliable with Ringer
  • Cardiac output (CO) indicated hypovolemia with 20% albumin

Further findings

Hemodynamic profile, Ringer-only program
313 · mean · mL

Hemodynamic profile, Ringer-only program

Slight hypovolemia; decreased mean arterial pressure (MAP), increased HR, PPV and vasopressor requirement

Vascular filling, albumin programs · 5 h observation period

5% and 20% albumin more effective in filling the vascular system: higher mean circulatory filling pressure, unchanged or decreased PPV
20% albumin increased systemic vascular resistance and resistance to venous return

Original publication

Detection of hypovolemia by non-invasive hemodynamic monitoring during major surgery using Ringer´s solution, 5% albumin, or 20% albumin as infusion fluid: a post-hoc analysis of a randomized clinical trial. Crit Care. Published 23 March 2025. doi:10.1186/s13054-025-05357-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.